| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/10/2007 | CN1893976A Radiation therapy and medical imaging using uv emitting nanoparticles |
| 01/10/2007 | CN1893974A Immunogenic compositions |
| 01/10/2007 | CN1893963A Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 01/10/2007 | CN1893961A Biologically active blood serum obtained by electroshock |
| 01/10/2007 | CN1893947A Use of siramesine in the treatment of cancer |
| 01/10/2007 | CN1893944A 3-cyano-quinoline derivatives with antiproliferative activity |
| 01/10/2007 | CN1893939A Composition for preventing and treating hepatoma |
| 01/10/2007 | CN1893925A In vivo targeting of dendritic cells |
| 01/10/2007 | CN1891825A Gene and protein relating to hepatocellular carcinoma |
| 01/10/2007 | CN1891819A Method for producing asparaginase by Erwinia fermentation |
| 01/10/2007 | CN1891717A Chemical modification method of endostatin and its use |
| 01/10/2007 | CN1891714A Ligand for herpes simplex virus entry mediator and methods of use |
| 01/10/2007 | CN1891704A Dipetidase tetrainhibitor, and its preparing method and use |
| 01/10/2007 | CN1891703A Chelerythrine compound and its preparing method |
| 01/10/2007 | CN1891699A Therapeutic morpholino-substituted compounds |
| 01/10/2007 | CN1891693A Therapeutic morpholino-substituted compounds |
| 01/10/2007 | CN1891290A Medicine for treating cancer |
| 01/10/2007 | CN1891247A Nano anticancer injection preparation and its preparing method |
| 01/10/2007 | CN1891246A Intravenous administration preparation extracted from marsdenia tenacissima stem |
| 01/10/2007 | CN1891240A Chinese medicine composition containing multi glossy ganoderma active constituents and its preparing method |
| 01/10/2007 | CN1891231A Liusheng Chinese medicine preparation and its preparing method |
| 01/10/2007 | CN1891223A Medicine containing forrest silk vine root orherb aglycone, and its preparing method and use |
| 01/10/2007 | CN1891221A Combination therapy to treat hepatitis b virus |
| 01/10/2007 | CN1891220A 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 01/10/2007 | CN1891211A Method for preparing curcumin lyophilized liposome |
| 01/10/2007 | CN1294269C Adenovirus carrier for specifically killing primary liver cancer cells and its application |
| 01/10/2007 | CN1294268C Recombinant adenovirus vector capable of being duplicated and spread specifically inside tumor cell |
| 01/10/2007 | CN1294255C Toxicide enzyme with aflatoxin activity conversion activity and gene for coding the enzyme |
| 01/10/2007 | CN1294151C Marine fungi polysaccharide and its extraction method and use |
| 01/10/2007 | CN1294148C Single-stranded cyctic trispecific antibody |
| 01/10/2007 | CN1294135C Pyrrolopyrimidines as protein kinase inhitibors |
| 01/10/2007 | CN1294132C Synthesis of temozolomide and analogs |
| 01/10/2007 | CN1294126C N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound and preparation method thereof |
| 01/10/2007 | CN1294120C Pyrrolidinyl metalloprotease inhibitor and its application |
| 01/10/2007 | CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 01/10/2007 | CN1293920C Process for preparing active target-directional carrier mediated by folic acid compound mediated |
| 01/10/2007 | CN1293917C DNA vaccine against proliferating endothelial cells and application thereof |
| 01/10/2007 | CN1293908C Cancer preventing and treating Chinese medicine with two kinds of snake and Ganoderma Lucidum seu Japonicum |
| 01/09/2007 | US7161035 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 01/09/2007 | US7161031 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 01/09/2007 | US7161002 Compounds as antiinflammartory agents, antiproliferation agents and and anticancer agents from cyclodehydration of compounds |
| 01/09/2007 | US7160981 Peptide antagonists of DP transcription factors |
| 01/09/2007 | US7160923 Polyamine analogues as therapeutic and diagnostic agents |
| 01/09/2007 | US7160915 N-methyl-substituted benzamidazoles |
| 01/09/2007 | US7160914 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer |
| 01/09/2007 | US7160909 Cyclopenta[b]indole derivatives as sPLA2 inhibitors |
| 01/09/2007 | US7160904 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 01/09/2007 | US7160903 Sulfonylaminocarboxylic acids |
| 01/09/2007 | US7160896 Therapeutic acridone and acridine compounds |
| 01/09/2007 | US7160895 Inhibiting the proliferation of tumor cells, using 6-chloro-1,9-dimethyl-3-phenyl-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one; anticancer treatment |
| 01/09/2007 | US7160893 Antiarthritic agents for treating osteoarthritis or rheumatoid arthritis, treating diseases from tissue breakdown such as heart disease, cardiovascular disorders, inflammatory bowel disease, multiple sclerosis; enzyme inhibitors |
| 01/09/2007 | US7160889 Quinazoline compounds |
| 01/09/2007 | US7160885 Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity |
| 01/09/2007 | US7160874 Phenylalanine derivatives |
| 01/09/2007 | US7160873 Texaphyrin coordination compounds and uses thereof |
| 01/09/2007 | US7160872 Methods to treat conditions mediated by chemokine receptors |
| 01/09/2007 | US7160868 Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors |
| 01/09/2007 | US7160860 Biosynthesis inhibition of oestrogen in an oestrogen-dependent breast tumor by administering a antitumor biodrug, Sant 7; aromatase, oestrone sulphatase, or oestradiol dehydrogenase inhibitors |
| 01/09/2007 | US7160856 Such as alpha-O-linked glycopeptides with clustered glycodomains which are useful as anticancer agents |
| 01/09/2007 | US7160686 Immunizing a rat with a suspension of fetal cells from the same genetic line, recovering spleen cells, separating lymphocytes, immunizing a second time with the lymphocyte suspension, recovering the antiserum, adding kidney, lung and liver cells, filtration; immunoassay |
| 01/09/2007 | US7160545 Useful for treatment and prevention of prostate cancer; is recognized by cytotoxic T lymphocytes |
| 01/09/2007 | US7160536 Radiolabelled metal transport proteins as imaging agents |
| 01/09/2007 | CA2309790C Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
| 01/09/2007 | CA2296731C Methods of preparing and purifying 9-nitro-20-camptothecin |
| 01/09/2007 | CA2286190C Gnrh antagonists being modified in positions 5 and 6 |
| 01/09/2007 | CA2270391C Ex-corpore method for treating human blood cells |
| 01/09/2007 | CA2232325C Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 01/09/2007 | CA2227533C Improved therapeutic agents |
| 01/09/2007 | CA2184262C Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same |
| 01/09/2007 | CA2176511C Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 01/09/2007 | CA2162732C Use of modified tall-104 cells to treat cancer and viral diseases |
| 01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
| 01/08/2007 | CA2528635A1 Tumor treatment using beta-sheet peptides and radiotherapy |
| 01/04/2007 | WO2007002808A1 Anti-nonmelanoma carcinoma compounds, compositions, and methods of use thereof |
| 01/04/2007 | WO2007002433A1 Pyrrolo [2, 3-b] pyridine derivatives as protein kinase inhibitors |
| 01/04/2007 | WO2007002325A1 Pyrrolo[2,3-b] pyridine derivatives as protein kinase inhibitors |
| 01/04/2007 | WO2007002272A1 Benzopyranone compounds for treating cancer |
| 01/04/2007 | WO2007002233A2 Low-toxicity, long-circulating chimeras of human interferon- alpha analogs and interferon tau |
| 01/04/2007 | WO2007002223A2 Cd19 antibodies and their uses |
| 01/04/2007 | WO2007002069A2 Serum biomarkers for breast cancer |
| 01/04/2007 | WO2007001939A1 Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities |
| 01/04/2007 | WO2007001851A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/04/2007 | WO2007001249A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 01/04/2007 | WO2007001200A1 Mature dendritic cells loaded with tumor polylysates and antitumoral vaccine base thereon |
| 01/04/2007 | WO2007001139A1 A composition for treating or preventing a cancer comprising pyrrolopyridine derivatives |
| 01/04/2007 | WO2007001080A1 Beverage/food and pharmaceutical comprising loquat leaf extract |
| 01/04/2007 | WO2007001049A1 Benzenoid ansamycin derivative |
| 01/04/2007 | WO2007000998A1 BIS(ARYLMETHYLIDENE)ACETONE COMPOUND, ANTI-CANCER AGENT, CARCINOGENESIS-PREVENTIVE AGENT, INHIBITOR OF EXPRESSION OF Ki-Ras, ErbB2, c-Myc AND CYCLINE D1, β-CATENIN-DEGRADING AGENT, AND p53 EXPRESSION ENHANCER |
| 01/04/2007 | WO2007000978A1 Physiologically active substance nk13650p3, method of producing the same and use thereof |
| 01/04/2007 | WO2007000935A1 Peptide derived from prostate-related protein as cancer vaccine candidate for prostate cancer patient who is positive for hla-a3 super-type allele molecule |
| 01/04/2007 | WO2007000924A1 Pharmaceutical composition comprising substance capable of inhibiting or promoting progranulin activity and screening method for substance capable of inhibiting or promoting progranulin activity |
| 01/04/2007 | WO2007000671A2 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 01/04/2007 | WO2007000618A1 Active fraction of a polar solvent extract from the latex of euphorbiaceae plants |
| 01/04/2007 | WO2007000473A1 Use of phthalocyanine derivates for the non-photodynamic treatment of diseases |
| 01/04/2007 | WO2007000383A1 Biphenyl and naphthyl-phenyl hydroxamic acid derivatives |
| 01/04/2007 | WO2007000328A1 Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof |
| 01/04/2007 | WO2006124996A3 Inhibitors of polo-like kinase-1 |
| 01/04/2007 | WO2006124462A3 Compounds and compositions as protein kinase inhibitors |
| 01/04/2007 | WO2006123113A3 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors |
| 01/04/2007 | WO2006117660A3 Method for treating cancer, coronary, inflammatory and macular disease, combining the modulation of zinc- and/or copper dependent proteins |